SCHEMBL30954112

SCHEMBL30954112

O=C(O)c1c(F)c(Cl)cc2c1OCCN2CCc1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
RORC P51449 1/20 0.36
PTGER4 P35408 1/20 0.36
PTGER2 P43116 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
MITF O75030 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
KDM5A P29375 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27434139 1.00 NAAA (0.38) NAAALIPGHPGDTSHRRORC
SCHEMBL27434250 0.94 NAAA (0.42) NAAALIPGHPGDTSHRPTGER4
SCHEMBL30954061 0.94 NAAA (0.42) NAAALIPGHPGDTSHRPTGER4
SCHEMBL30954165 0.92 MAPT (0.38) TSHRRORCSMN1; SMN2MITFALDH1A1
SCHEMBL27434123 0.87 MAPT (0.40) SMN1; SMN2MITFALDH1A1HTTRAB9A
SCHEMBL30954115 0.86 MAPT (0.36) NAAASMN1; SMN2ALDH1A1HTTRAB9A
SCHEMBL27434074 0.83 AR (0.41) HPGDTSHRALDH1A1HDAC1HDAC6
SCHEMBL27434163 0.83 AR (0.36) HPGDTSHRSMN1; SMN2ALDH1A1HTT
SCHEMBL30954145 0.83 AR (0.36) HPGDTSHRSMN1; SMN2ALDH1A1HTT
SCHEMBL27434239 0.81 MAPT (0.39) NAAAALDH1A1HTTRAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed